00000000nam 2200000zi 4500
0019.944180
003CaOODSP
00520250303144943
006m     o  d f      
007cr mn|||||||||
008241016e202502##onc     ob   f000 0 eng d
020 |a9780660740447
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-249/2024E-PDF
24500|aReporting adverse events following immunization (AEFI) in Canada : |buser guide to completion and submission of the AEFI reports.
2463 |aUser guide : |bAEFI report form
250 |a[February 2025 edition].
264 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cFebruary 2025.
264 4|c©2025
300 |a1 online resource (35 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Déclaration de manifestations cliniques inhabituelles (MCI) à la suite de l'immunisation au Canada : guide de l'utilisateur pour remplir et soumettre les rapports de déclaration de MCI.
500 |aCover title.
500 |aIncorrect catalogue number (HP40-249/2025E-PDF) printed in this edition.
504 |aIncludes bibliographical references.
650 0|aImmunization|xComplications|zCanada.
650 0|aVaccination|xComplications|zCanada.
650 0|aDrugs|xSide effects|xReporting|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tDéclaration de manifestations cliniques inhabituelles (MCI) à la suite de l'immunisation au Canada : |w(CaOODSP)9.944181
795 |tReporting adverse events following immunization (AEFI) in Canada : |b[October 2023 edition]|w(CaOODSP)9.932167
85640|qPDF|s519 KB|uhttps://publications.gc.ca/collections/collection_2025/aspc-phac/HP40-249-2024-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/immunization/reporting-adverse-events-following-immunization/user-guide-completion-submission-aefi-reports.html
986 |a240580